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Abstract
Background: Forward genetic screens in mice provide an unbiased means to identify genes and other functional
genetic elements in the genome. Previously, a large scale ENU mutagenesis screen was conducted to query the
functional content of a ~50 Mb region of the mouse genome on proximal Chr 5. The majority of phenotypic
mutants recovered were embryonic lethals.
Results: We report the high resolution genetic mapping, complementation analyses, and positional cloning of
mutations in the target region. The collection of identified alleles include several with known or presumed
functions for which no mutant models have been reported (Tbc1d14, Nol14, Tyms, Cad, Fbxl5, Haus3), and
mutations in genes we or others previously reported (Tapt1, Rest, Ugdh, Paxip1, Hmx1, Otoe, Nsun7). We also
confirmed the causative nature of a homeotic mutation with a targeted allele, mapped a lethal mutation to a large
gene desert, and localized a spermiogenesis mutation to a region in which no annotated genes have coding
mutations. The mutation in Tbc1d14 provides the first implication of a critical developmental role for RAB-GAP-
mediated protein transport in early embryogenesis.
Conclusion: This collection of alleles contributes to the goal of assigning biological functions to all known genes,
as well as identifying novel functional elements that would be missed by reverse genetic approaches.
Background
Since the human and mouse genomes were sequenced
several years ago, it has been recognized that the next
major challenge is to uncover the functional content of
the genome. This was a motivation behind large scale
projects such as ENCODE (Encyclopedia of DNA ele-
ments) and KOMP (Knockout Mouse Project; http://
www.nih.gov/science/models/mouse/knockout/komp.
html). The former used molecular strategies to identify
features of human chromatin [1], and the next iteration
(modENCODE) is geared to identifying functional geno-
mic elements in vivo using non-vertebrate models
http://www.genome.gov/26524507. KOMP uses a reverse
genetic approach to identify the functions of all known
and annotated mouse protein coding genes, by generat-
ing germline or conditional null alleles in embryonic
stem (ES) cells.
Forward genetic mutagenesis in mice is most com-
monly conducted via whole animal mutagenesis with
the point mutagen N-ethyl-N-nitrosourea (ENU) [2].
This approach has succeeded in identifying new genes
that play important roles in biological processes and in
modeling disease [3-8]. Two key advantages over reverse
genetics are that: 1) ENU can cause non-null alleles,
enabling the dissection of protein function and yielding
variants that are more relevant to disease-causing muta-
tions in humans; and 2) as a non-biased approach,
genetic elements or genes can be identified that would
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activities or roles.
In multiple organisms, point mutagens have been
employed in two basic strategies: random and region-
directed. The former has the benefit of scanning the
whole genome, whereas the latter allows one to focus
resources on a microcosm of the genome. Several years
ago, we initiated a larger scale regional screen of proxi-
mal mouse Chr 5 spanned by an inversion called rump-
white (Rw). This recessive lethal balancer facilitated the
isolation and maintenance of mutations recovered in the
screen. Predominantly lethal mutations were recovered
(a total of 37) [9]. Here, we report on the mapping and
cloning of much of this collection. Several mutations
were identified in genes for which no models previously
existed, providing new biological insights and models of
interest. Intriguingly, we also mapped one mutation to a
gene desert, in which the nearest protein-coding gene is
over 1 megabase away.
Results and Discussion
Mutation Mapping
The rough locations of the Rw region ENU-induced
mutations were reported by Wilson et al [9], with most
of them being localized to intervals that were too large
to allow effective candidate gene selection. Additionally,
since many of the mutations were located in common
large intervals, allelism amongst them was possible. To
map the mutations at higher resolution, we continued
and expanded upon two strategies initiated by Wilson
et al: deletion mapping and recombination mapping [9].
In the deletion mapping approach, complementation
tests between nearly all the lethals and relevant Dpp6,
Hdh and Qdpr deletions were completed (Figure 1).
Various smaller deletions in each complex (e.g. Dpp6
df4J,
Hdh
df9J, Qdpr
df6J and others shown in Figure 1) were
used to better refine locations of noncomplementing
lethals. Importantly, complementation of mutations by
deletions also provided useful information by excluding
large regions. The map positions of L5Jcs6, 15, 16 and
24 were determined in large part by the fact that they
are complemented by both Dpp6
df1J and Hdh
df7J.
Recombination mapping of mutations was performed as
described in Methods.
The mutation mapping is summarized in Figure 1.
Several of the embryonic lethal mutations mapped near
or beyond the distal end of the Rw inversion, and these
lines were not maintained (most are not shown here,
but are presented in [9]). Figure 1 and Table 1 also indi-
cate those cases in which the mutated gene has been
identified (or likely so). At present, 16 mutants have
been identified from the original 37 that mapped within
or near the Rw inversion region. Not surprisingly, the
mutations cluster to regions that are dense in RefSeq
gene annotations (Figure 1). An exception is L5Jcs13,
which maps to gene desert (discussed below).
Complementation analyses of the mutant collection
Because ENU mutagenesis is random, some of the muta-
tions may be alleles of the same gene. An allelic series
can give insight into protein function. This proved to be
the case with L5Jcs4 and L5Jcs36, alleles of Paxip1 (Ptip)
with differing severity [10]. Furthermore, multiple alleles
can solidify evidence that the mutated gene indeed corre-
sponds to the observed phenotype. Accordingly, we eval-
uated each mutation for potential allelism with the entire
mutant collection. Rather than performing complementa-
tion tests between all possible pairwise combinations by
breeding, we exploited the fact that mutation pairs with
non-overlapping map positions cannot be alleles (unless a
gene spans adjacent genetic intervals). This greatly
reduced the number of potential complementation tests
(37 × 36 = 1332) to a subset that co-localized at the time
of analysis. Mutations that went extinct before positional
cloning and completion of complementation analyses,
and most of those that potentially map distal to the Rw
inversion, are not included. The results are summarized
in Figure 2. In sum, we identified allelism between four
pairs of mutations: Paxip1
L5Jcs4 /Paxip1
L5Jcs36 [10],
Cad
L5Jcs24/Cad
L5Jcs27 (Ching & Schimenti, in preparation),
Nop14
L5Jcs7/Nop14
L5Jcs14 and L5Jcs6/L5Jcs35 (gene not yet
identified).
Positional Cloning of Mutations
Once mutations were mappedt oi n t e r v a l su n d e r5c M ,
or to regions containing a small number of annotated
genes, we initiated searches for causative mutations. The
strategies varied during t h ec o u r s eo ft h ep r o j e c ta s
technology advanced. In most cases, annotated genes
were prioritized for mutational analysis by considering
the following: 1) phenotypes of described knockouts;
2) whether the genes had orthologs in other species
with mutant phenotype information; and 3) gene expres-
sion patterns from microarrays or EST library origins.
Primer pairs were then designed to amplify exonic
sequences from the prioritized candidate genes, using
genomic DNA of mutant heterozygotes (or homozygous
embryonic material in some cases) as templates. PCR
products were analyzed by denaturing HPLC (to detect
mismatches as heteroduplexes) or direct sequencing.
This led to the identification of several mutations sum-
marized below. The causative nature of the identified
mutations is relatively confident in cases where two
alleles were identified, or when the mutated gene has a
similar knockout phenotype.O t h e r w i s e ,f o l l o w - o nc o n -
firmation of causality will be required by methods such
as non-complementation with a targeted or gene-trap
allele (as in the case of Tapt1; see below).
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Page 2 of 10The following paragraphs in this section describe posi-
tional cloning of new alleles, or relevant additional
information on previously identified alleles. Table 1 also
overviews all alleles identified in this project.
L5Jcs1
This perinatal lethal mutation was identified previously
as affecting a novel gene, Tapt1 (Transmembrane ante-
rior posterior transformation 1) [11]. Homozygous
mutants exhibit homeotic transformation of the skele-
ton. To confirm that the point mutation is causative for
the phenotype, we performed a complementation test
between L5Jcs1 and a mice carrying a deletion allele of
Tapt1 (Tapt1
KO; see Methods). Intercrosses between
Tapt1
KO/Rw and L5Jcs1/Rw animals produced litters (N
= 31 pups) in which only Rw offspring (21) survived to
wean age. The remaining animals (10) died shortly after
birth, before the Rw phenotype could be determined.
Given that Rw/Rw causes embryonic lethality shortly
after gastrulation, the expected number of non-Rw ani-
mals for those surviving to wean age is 7, and the lack
thereof is significant (Chi square = 10.5; P = .0012).
This confirms that the mutation in Tapt1 is causative
for the L5Jcs1 lethal phenotype, and indicates that
Tapt1
L5Jcs1 is a null or severe hypomorph.
L5Jcs5 (Tbc1d14)
This mutation was mapped with a combination of F2
crosses and deletion non-complementation. It resides
within the Hdh
df7J deletion region, but the proximal end
was better defined by mapping of recombination break-
points. It was originally identified as a pre-E9.5 embryo-
nic lethal of undefined phenotype [9]. We performed
timed matings to better characterize the developmental
phenotype. Embryonic development was disrupted at a
very early point post-implantation. At E7.5, when WT
embryos have progressed to a late primitive streak stage,
mutant embryos are smaller and appear arrested at an
egg cylinder-like stage (Figure 3a).
L5Jcs5 was mapped to a 1.6 Mb region containing ~17
genes whose knockout phenotypes are not known.
Sequencing of several of these genes (not all to comple-
tion) revealed only 1 mutation in Tbc1d14.T h i sg e n e
encodes a protein containing a TBC (Tre-2/Bub2/
Cdc16) domain characteristic of RAB-GAPs, proteins
that activate GTPase activity of RAB proteins [12,13].
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Figure 1 Map of mutations in Rw region. The proximal region of Chr. 5 is depicted as a horizontal line, with the centromere (filled circle) on
the left. The region spanned by the Rw inversion is indicated above. Map positions (in megabases, accordingly to mouse genome Build 37) are
indicated. Microsatellite loci are abbreviated by exchanging the prefix “M” for “D5Mit“ and “J” for “D5Jcs“. Deletions are indicated as horizontal
rectangles, and are color coded with the locus at which they were induced (red) Dpp6; (blue) Hdh; (green) Qdpr. The amount of DNA known to
be absent in each deletion is spanned by the rectangles. The thin lines extending from the ends of the rectangles indicate the regions in which
the deletion breakpoints reside. The intervals containing certain lethal mutations (abbreviated as “L#”) are bracketed at the bottom of the map.
The end points of the brackets correspond to markers on the map above. Cloned mutations are shown above the map. Uncloned lethal
mutations that are no longer extant are greyed out names. The locations of RefSeq genes are indicated at the top. This depiction is a modified
screenshot from the UCSC browser. Note that some genes have multiple isoforms, all of which are indicated.
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iate membrane-associated protein transport. The muta-
tion causes a SER > GLY change in amino acid 433
(NP_001106833; or 413 for NP_598671), which resides
in the TBC1 domain. This amino acid is conserved in
mammals (dog; human), zebrafish and chickens. There
have been no studies regarding the function of
TBC1D14 in cells or animals, however the crystal struc-
ture of the human protein has been reported [14].
Interestingly, none of the 39 mouse genes annotated
as a RAB-GAP (Gene Ontology term: Rab GTPase acti-
vator activity; GO:0005097) has been associated with a
mutant phenotype of embryonic lethality. Thus, if
indeed the Tbc1d14 mutation proves to causative for
the L5Jcs5 phenotype, this would be the first implication
of a critical developmental role for RAB-GAP-mediated
protein transport in early embryogenesis.
L5Jcs7/L5Jcs14 (Nop14)
Pooled recombination mapping data of these two non-
complementing mutations localized the culprit gene to a
600 kb interval containing 13 RefSeq genes. Mutations
in Nop14 were identified by next-gen sequencing of
hybrid-selected exonic sequences (see Methods), and
verified by Sanger sequencing (Figure 4). L5Jcs7 alters
the exon 3 splice acceptor sequence (AG|CG >GG|CG)
of this 18 exon gene, whereas L5Jcs14 causes a prema-
ture stop codon in exon 3. Based on homology to yeast
orthologs, this gene is annotated as “nucleolar protein
homolog 14,” and is involved in ribosome biogenesis
[15]. The pre- or peri-implantation lethality caused by
these mutations [9] is consistent with such a fundamen-
tally important cellular role.
Table 1 Positional Cloning of Mutations Summary
Allele Gene Mutation Genetic Interval Gene Function Refs
L5Jcs1 Tapt1 ** see ref see ref Mutations causes homeotic-like skeletal transformations and
perinatal lethality.
[11]
L5Jcs4
L5Jcs36
Paxip1 ** see ref see ref Vasculogenesis; DNA repair; epigenetic regulation [10,36]
L5Jcs5 Tbc1d14 missense in TBC1 domain M4-J57 (1.6 Mb) TBC1 domain family; putative RAB GTPase activation protein.
L5Jcs7
L5Jcs14
Nop14 SA site, exon 3 nonsense,
exon 3
J36-M268 600 kb Nucleolar protein homolog; ribosome biosynthesis.
L5Jcs11 Tyms T > A (ASN > LYS) J63-M176 (1.1 Mb) Thymidylate synthase
L5Jcs37 Rest * C893G (P > R) RE1-silencing transcription factor [37]
Dumbo Hmx1** see ref see ref Homeobox-containing gene [38]
L5Jcs24
L5Jcs27
Cad See ref M251-M334 M387-
M353
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase,
and dihydroorotase.
in prep^
L5Jcs31 Haus3 missense LEU > PRO in
exon 4.
M388-J88 (1.8 Mb) Subunit of augmin (HAUS) complex that regulates centrosome
and spindle integrity.
L5Jcs32 Fbxl5 missense MET > LYS M105-J614 Part of E3 ubiquitin ligase complex that regulates iron
homeostasis.
[22,23]
L5Jcs8 Ugdh * nonsense D5Ncnp1-J24
(1.3Mb)
UDP-glucose dehyrogenase; GAG biosynthesis; gastrulation. [39]
Ste5Jcs1 Nsun7 ** see ref see ref Required for normal sperm motility and male fertility. [40]
Deaf5Jcs1 Otof ** see ref see ref Otoferlin; inner hair cell neurotransmission [41]
*Separate alleles reported by others. ** Positional cloning of this allele previously reported. M = D5Mit;J=D5Jcs. Bolded alleles highlight that two alleles were
identified. ^Ching & Schimenti et al will report on these alleles elsewhere. Alleles beginning with “L” are embryonic lethals; timing of lethality was reported
previously [9].
Figure 2 Complementation and allelism analyses.T h eg r i d
shows all pairwise comparisons of Rw-region lethal mutations for
potential allelism. Original mutations located distal to Rw are not
included, nor is L5Jcs17, which went extinct before mapping and
allelism testing could be completed. Actual complementation tests
were, in most cases, only performed when mutations co-mapped to
overlapping genetic intervals (dark green or red). The majority of
mutations were mapped to sufficient resolution to indirectly
conclude they are not allelic (light green).
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L5Jcs11 is an early postimplantation mutant overtly
defective in gastrulation [9]. It was mapped genetically
to a ~1.1 Mb interval by a combination of deletion map-
ping (Dpp6
df4J complemented L5Jcs11, defining the
proximal end as being distal to D5Jcs63) and recombina-
tion mapping (defining the distal end of the critical
region). Sequencing of candidate genes in the region
identified a T > A transversion in the third nucleotide
of the codon encoding amino acid 106 of TYMS. This
causes a predicted asparagine to lysine change. The
structure and function of thymidylate synthase has been
characterized extensively in various eukaryotes. The pro-
tein is a symmetric dimer, with each subunit ranging
from 30 to 35 kDa depending on the organism.
However, in protozoa and plants, TYMS and DHFR are
produced on the same polypeptide (reviewed in [16]).
The main role of TYMS is to convert deoxyuridine
monophosphate (dUMP) to deoxythymidine monopho-
sphate (dTMP) using a 5,10-methylenetetrahydrofolate
cofactor. dTMP is essential for the synthesis of DNA
but not RNA, and therefore it is found at especially high
levels in cells undergoing rapid cell division. Conse-
quently, anti-TYMS drugs are used in cancer treatment,
as are other chemicals that inhibit this pathway (such as
methotrexate, a DHFR inhibitor) [17]. TYMS inhibitor
drugs primarily target the dUMP substrate or the folate
binding site on TYMS.
Since ASN106 is not specified as being a residue
essential for TYMS function [18], we sought additional
evidence that the mutation is responsible for the drastic
phenotype of L5Jcs11. TYMS autoregulates its levels by
binding its mRNA to decrease translation [19]. Consis-
tent with a decrease in functional TYMS in cells bearing
this allele, Western blots revealed that L5Jcs11 heterozy-
gotes have ~2.6 fold elevated TYMS protein in the liver
relative to WT mice (Figure 3b). Mutant heterozygotes
also exhibited 2.3 fold lower DHFR protein levels (Fig-
ure 3b). ASN106 is located close to the folate binding
motif of TYMS, suggesting that the enzyme is defective
in binding or effectively utilizing the major substrate N5,
N10-Methylene H4 folate.
To further explore the effects of this mutation on
mice, we performed inner cell mass (ICM) outgrowth
assays. As shown in Figure 3c, although trophoblast
cells from cultured blastocysts could grow, consistent
with the ability to implant, mutant ICMs were unable to
outgrow from hatched embryos. This indicates that the
rapid cell division and DNA synthesis occurring in
WT
E7.5
E7.5 Blastocyst 
outgrowths, 4d
WT
L5Jcs11//L5Jcs11
L5Jcs5/L5Jcs5
E7.5
A
B
ICM
Tr
WT L5Jcs11/+
C
DHFR
β-actin
TYMS
β-actin
Figure 3 Phenotypes of L5Jcs5 and L5Jcs11 mutants.( A )L i g h t
micrographs of E7.5 WT and L5Jcs5/L5Jcs5 littermates taken at same
magnification (8×). (B) Western blots of liver protein probed with
anti-TYMS, DHFR, and beta actin. Each lane contains protein from
separate animals. (C) Light micrographs of whole mount E7.5 WT
and L5Jcs11/L5Jcs11 embryos, plus representative images of
blastocyst outgrowths from the indicated genotypes. The mutant
embryo is magnified 1.5 X compared to the WT. Notice that there is
no evidence of growth of the embryo proper. ICM = Inner cell
mass. Tr = trophectoderm.
L14/Rw 
+B6/Rw 
L7/Rw 
TAA = STOP in L14  Splice mutation in L7 
L= “L5Jcs” 
B6=C57BL/6J
Figure 4 Mutations in Nop14. DNA sequence traces from DNAs of
the indicated genotypes, corresponding to 5’ end of Nop14 exon 3
(a.k.a. Nol14), are aligned against the corresponding region from the
UCSC gene browser track. The alternating dark/light blue boxes
contain the encoded amino acids in exon 3.
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TYMS function, consistent with failed postimplantation
development of the embryo proper.
L5Jcs31 (Haus3)
This mutation was found by high-throughput sequen-
cing of hybrid-selected exon DNA. It is a T > C transi-
tion resulting in a LEU > PRO change in the fourth of 5
Haus3 exons. Currently, Haus3 is annotated as residing
in the first intron of the Poln gene, in the same tran-
scriptional orientation. However, this may be artifactual
or not biologically relevant, since the putative exon 1 of
Poln is: 1) non-coding; 2) shared with Haus3; 3) present
in only 1 of >120 spliced ESTs aligned in the UCSC
browser; 4) absent from human POLN; and 5) absent
from other mammalian Haus3 genes (Figure 5). How-
ever, the recovery of “full-length” cDNA clones indicates
that Poln mRNAs can be produced that contain this
mRNA, as do many Haus3 transcripts (ESTs not
shown). It remains to be seen if these two genes share a
promoter/enhancer, or even a common transcriptional
start site.
HAUS3 is a component of the multiprotein HAUS
complex, homologous to the Drosophila Augmin com-
plex. In mammalian cells, HAUS regulates centrosome
and spindle integrity. Its disruption causes destabiliza-
tion of kinetocore microtubules and centrosome disrup-
tion, and thus is critical for genome stability [20].
Interestingly, HAUS3 was found to be mutated early in
the development of a subset of lobular breast cancers
[21]. Though we haven’t noted any obvious defects in
heterozygous animals, this model might be useful for
investigating the effects on breast cancer frequency or
progression in tumor susceptible backgrounds. Homo-
zygosity for L5Jcs31 causes pre- or peri-implantation
lethality, indicating the essential nature of the augmin
complex in mammalian cell growth or early
development.
L5Jcs32 (Fbxl5)
This mutation was identified as a midgestation recessive
l e t h a ls h o w i n gn e u r a lt u b ed e f e c t s[ 9 ] .T h ea l l e l ew a s
mapped by virtue of non-complementation with the
Hdh
df9J deletion. Sequencing of candidate genes in the
region led to the identification of a T to A transition in
exon 3 of Fbxl5, resulting in the replacement of methio-
nine by lysine at amino acid position 127.
FBXL5 (F box and leucine-rich repeat protein 5) is part
of an SCF (SKP1-cullin-F-box) ubiquitin ligase complex
that plays a key role in regulating iron homeostasis
[22,23]. It serves as a sensor of iron and oxygen levels by
tethering the iron regulatory proteins IRP1/2 to an E3
ligase complex for ubiquitination and proteasome degra-
dation, or alternatively, increasing transferrin receptor
transcription and inhibiting ferritin production under
conditions of low intracellular iron. The mutation resides
in the conserved iron-binding hemerythrin domain of
FBXL5, changing a highly conserved (invariant among
vertebrates) MET immediately following a key histidine
residue that is involved in coordinating Fe [22]. We pos-
tulate that this compromises or eliminates iron binding
by the protein, thus disrupting its sensor function. Our
findings that mutation of Fbxl5 causes embryonic lethal-
ity underscores the known critical nature of iron home-
ostasis during development (reviewed in [24]).
The L5Jcs13 embryonic lethal allele maps to a gene
desert
This mid-gestation embryonic lethal mutation was
recombination-mapped to a 289 kb interval between
SNP markers rs13478279 (60,593,878) and rs13478280
(60,882,847). No protein-coding genes or spliced ESTs
are annotated in this region (Figure 6), nor are any
known microRNAs. There appears to be an intronless,
ORF-containing transcription unit (represented by two
ESTs), with homology to transcripts in humans and
weasel (Figure 6). However, no mutations were detected
in the region spanned by the ORF in the L5Jcs13 allele
(data not shown). We also sequenced an apparent pro-
cessed pseudogene with homology to human POGK,
and a conserved region corresponding to an unspliced
EST EL606540, but again no mutations compared to the
parental B6 sequence were found. Finally, approximately
59% of the critical region was scanned for mutations by
shotgun sequencing of pooled PCR amplimers from
L5Jcs13/Rw genomic DNA (see Methods). No de-novo
mutations were found.
RefSeq Genes
Mouse mRNAs from GenBank
Poln
Haus3
Homo POLN
Homo HAUS3
Bos HAUS3
Rattus Haus3
AK133063
AY135562
BC027393
Transcription
part of Poln?
absent from 
most  Poln  ESTs
*
Figure 5 Structure of Haus3 locus. Shown are the following tracks
from the UCSC browser (July 2007 NCBI37/mm9 assembly): Mouse
RefSeq (red), Other Refseq (blue), and Mouse mRNAs (black). Refseq
annotates Haus3 as being within the first intron of Poln, presumably
based on the 2 “full length” mRNAs AK133063 and AY135562, which
include a small 5’ noncoding exon (far right). Interestingly, this exon
was also found in a Haus3 full length mRNA as well as several
spliced ESTs (not shown), but in only one spliced Poln EST (not
shown). We posit that this 5’ exon is not a normal part of Poln
transcripts, but that occasional transcription initiated in that exon
generally produced Haus3 mRNAs, but that occasionally there is
readthrough to produce a Poln mRNA. Note that human, rat and
cow Poln Refseq annotations do not include that exon, depicting
the two genes as non-overlapping (with the exception of a
potentially artifactually long 3’ end of HAUS3 in the human). The
L5Jcs31 mutation in Haus3 is indicated by an asterisk.
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within a much larger gene desert that contains only 1
RefSeq gene (Pcdh7) in 7.7 Mb. The nearest gene is
G6pd2, located 1.3 Mb distally, which marks the begin-
ning of a gene rich region. The current data raises the
possibility that the L5Jcs13 mutation affects a long range
regulatory sequence, as appears to be the case with an
ENU-induced allele of the quaking gene that is located
40-640 kb upstream [25], or the callipyge point muta-
tion in sheep that affects transcription of genes up to
several hundred kilobases away [26-28]. Alternatively,
the mutation could disrupt the local chromatin struc-
ture, or interaction of chromatin with the nuclear
matrix, in a manner that affects the expression of other
genes. Finally, it is possible that there is an uncharacter-
ized non-coding RNA in the critical region that is
mutated. There is one reported case of a mouse ENU-
induced mutation in a microRNA gene causing progres-
sive hearing loss [29].
Ste5Jcs3 maps to a region lacking mutated genes with
mutations or implicated spermatogenesis roles
This spermiogenesis mutation was localized to a 1.6 Mb
region (Figure 1) containing 4 annotated genes:
Tbc1d19, Rbpj, Cckar and Stim2. We sequenced all of
these (cDNA or exons from genomic DNA) and found
no mutations. Additionally, the latter 3 have been
mutated by gene targeting to produce phenotypes not
consistent with specific male infertility. CCKAR-
deficient mice are viable with no fertility defects [30,31].
Mutation of Rbpj causes embryonic lethality. Stim2 null
mice are slightly runted and die by 4-5 weeks of age
[32]. That study reported T cell defects but did not
address germ cell development. Tbc1d19 appears to be
widely expressed based on EST library representation
(Unigene), and, like Tbc1d14 (mutated in L5Jcs5),
encodes a likely Rab-Gap containing the TBC domain.
Further sequencing analyses will be required to identify
the mutation and determine if it affects a novel element,
the expression of any of these genes, or the expression
of genes located outside the genetically defined interval.
Conclusions
This report summarizes work on a region-specific
saturation mutagenesis project that was initiated before
the mouse genome was sequenced. We reasoned that
such regional screens (using deletions or balancer inver-
sions such as Rw) provided powerful advantages for phe-
notype characterization and gene identification,
including simplified stock maintenance using a single
visibly marked balancer chromosome, and the knowl-
edge of a mutation’s location. Coupled with nested dele-
tions generated in the same region [33], it was possible
to rapidly sublocalize mutations to regions upon which
to concentrate recombination mapping and guide effi-
cient complementation analyses. The sum of this work
was the molecular identification of 16 mutant alleles
representing 13 genes. For 10 of these genes, the
m u t a n t sa r e / w e r et h ef i r s tr e p o r t e di nm i c e( T a b l e1 ) ,
and 6 are presented here for the first time. The remain-
ing mutations have been mapped to relatively small
intervals.
Perhaps the most interesting mutation thus far is
L5Jcs13, which is a recessive embryonic lethal allele
mapping to a gene desert. Clearly, this region contains a
sequence element of crucial importance to mouse devel-
opment, and close scrutiny of this region for evidence of
cryptic genes (using ab initio gene prediction programs),
highly conserved elements or transcription units have
not revealed any candidate elements that contain muta-
tions (data not shown). In an era where all protein-cod-
ing genes will soon be knocked out in ES cells by the
KOMP project, the identification of apparently novel,
non-genic, essential genomic elements such as L5Jcs13
underscores the continuing value of unbiased forward
genetic screens.
The drawback of forward genetic screens in mice has
been the cost and time involved in identifying causative
mutations. For genome-wide screens, genetic crosses
must be conducted in order to localize mutations, fol-
lowed by traditional positional cloning efforts guided by
candidate gene prioritization. Region-specific screens
ameliorate the mapping part, and in one study the
approach was taken to directly resequence all exons
(and their flanking sequences) in the target region to
identify causative mutations [4]. Potentially causative
mutations were identified in 31 of the 41 mutant lines
examined, and most of the potentially causative
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Figure 6 L5Jcs13 maps to a gene desert. Shown are adaptations
of UCSC browser displayed with selected tracks (July 2007 NCBI37/
mm9 assembly). On top is the entire critical region to which L5Jcs13
maps (289 kb) with all annotated mouse and non-mouse ESTs. A
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the transcription unit. The failure to identify the other
10 mutations amongst annotated genes, and the cases of
L5Jcs13 and Ste5Jcs5, indicate that there is much we
don’t know about the functional content of the genome.
Furthermore, we must caution that for the potentially
causative mutations presented here and in other studies
such as the aforementioned, functional validation must
be obtained. This caveat also underscores the value of
genetic mapping, which contributes to validation of a
mutation identified by sequencing.
The advent of high-throughput DNA sequencing tech-
nologies can be transformative for forward genetics in
mice. Here, we identified three mutations by Solexa/Illu-
mina resequencing of exon-enriched DNA from critical
regions. However, the rapidly declining cost of whole
genome sequencing will soon negate the benefit of such
sequence enrichment, or even genetic mapping in
advance of sequencing (bearing in mind the issue of vali-
dation mentioned above). Additionally, whole genome
sequencing has the important advantage of enabling the
identification of non-coding regulatory elements.
Methods
Sequence capture and next generation sequencing
A custom Agilent oligonucleotide array was designed to
sequence exons, UTRs and promoters of all RefSeq genes
in non-recombinant intervals of several mutations (from
this and unrelated projects). The array included all RefSeq
genes between D5Mit388 and D5Mit268 (mm8; NCBI
Build 36). Solution-based hybrid capture of L5Jcs14/+
B6,
L5Jcs31/+
B6 and C57BL/6J genomic DNAs to transcribed
RNA oligonucleotide baits was performed as described
[34]. Libraries made from captured DNA were sequenced
using 51 or 76 bp paired-end reads with an Illumina Gen-
ome Analyzer. Candidate single nucleotide changes were
identified by 1) aligning high quality sequence reads to the
reference C57BL/6J mm8 genome sequence, 2) identifica-
tion of single nucleotide polymorphisms (SNPs) between
each sample against the reference, and 3) filtering for het-
erozygous SNPs unique to the mutant sample. In addition
to Sanger sequencing, genotyping of L5Jcs14 SNPs with
the Sequenom iPlex technology was performed to confirm
the L5Jcs14 mutation.
For L5Jcs13, 70 primer pairs were developed to
amplify the 289 kb critical region. The products aver-
aged a length of 4.5 kb and overlapped approximately
400 bp on each end. Amplification was initially
attempted on all products using Roche Expand Long
Range Polymerase or iProof Polymerase (Bio-Rad). Out
of the 70 primer pairs, 51 showed some level of success-
ful amplification. Amplimers were treated with FastAP
Alkaline Phosphatase plus Exonuclease I, pooled, then
sequenced on an Illumina GA genome analyzer using
chemistry that generated 43 nucleotide, single-end
reads. The sequence was aligned to C57BL/6J ("B6”)
genomic sequence using Novoalign v2.07 and Stampy
1.0.9. Further comparison was done with the C3H/HeJ
reference sequence from the Sanger Institute. Data was
analyzed for single nucleotide polymorphisms (SNPs),
insertions, and deletions using GATK v 1.4418 (The
Genome Analysis Toolkit; http://www.broadinstitute.
org/gsa/wiki/index.php/The_Genome_Analysis_Toolkit)
and VarScan v 2.2.3 http://sourceforge.net/projects/vars-
can/. Candidate SNPs were compared to the NCBI SNP
database dbSNP, and ultimately re-sequenced by stan-
dard methods to resolve whether a nucleotide difference
was a SNP, a mutation, or a database or sequencing
error.
Generation of Tapt1 mice
ES cells containing a deletion of the entire Tapt1 locus
were obtained from the KOMP Repository (clone name
Tapt1_AG12, produced by Regeneron, Inc.). The tar-
geted cells were of strain C57BL/6N, and the official
allele name is Tapt1
tm1(KOMP)Vic. Cells were microin-
jected into albino CD1 blastocysts to produce chimeras.
Western blot analysis
Snap-frozen liver samples were lysed in 10 mM Tris, pH
7.4, 150 mM NaCl, 5 mM EDTA, 5 mM DTT, 1%
Triton X-100, and Mammalian Protease Inhibitor Cock-
tail (Sigma). Tissue lysates were loaded onto 12%
SDS-PAGE gels with 25 μg total protein/lane; protein
concentrations were determined using the Lowry-
Bensadoun method [35]. Proteins were then transferred
to an Immobilon-P PVDF Membrane (Millipore). The
membrane was blocked overnight at 4°C in phosphate-
buffered saline with 10% nonfat dry milk and 1% NP40.
The membrane was incubated for two hours at room
temperature in one of two primary antibodies: 1:1000
-anti-TYMS (Zymed) or 1:2000 anti-DHFR (Sigma).
After four washes (phosphate buffered saline with 0.1%
Tween-20) of 10 minutes each, the membranes were
incubated for 1 hour in 1:10,000 HRP-conjugated goat
anti-mouse antibody for TYMS or 1:20,000 HRP-conju-
gated goat anti-rabbit for DHFR (Pierce). After four
washes of 10 minutes each, membranes were developed
in SuperSignal West Pico Chemiluminescent Substrate
(Pierce) and films exposed. As a loading control, mem-
branes were also probed with 1:100,000 HRP-conjugated
anti-beta actin (Abcam). Quantification of protein bands
was done by digitizing the films, then analyzing the
images with ImageJ software (NIH).
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Blastocysts (E3.5) were plated onto gelatinized tissue
culture dishes, cultured for 5 days in ES cell medium, and
harvested for genotyping as described previously [10].
Mutation Mapping and screening
For recombination mapping, Rw/L5Jcs# animals were
crossed to C5Cast/C5Cast (a strain in which the proxi-
mal portion of Chr 5 from Mus castaneous was ren-
dered partially congenic in strain C3HeB/FeJ), and non-
Rw F1 progeny (L5Jcs#/C5Cast) were intercrossed to
produce F2’s. Genomic DNA isolated from tails from F2
animals were genotyped with polymorphic markers
within the Rw region to identify recombinants. The
locations of the mutations were determined indirectly,
in that we excluded intervals in which a mutation
resides by virtue of being able to obtain homozygosity
for the parental B6 allele in live offspring.
Markers not in the MGD database are:
D5Jcs640 GCCAGGTTAATACAAGCTCCA and
TCTCCTTCTTCCTTCTCTTCTCTTC
D5Jcs85 GGGCTTTTAGACGAGCAGAG and
TGGGTTCAGAACGAAGGTCT
D5Jcs24 AAACATGTCAGGGCCAGAAG and
TGTGCTTCCATTCATTTATGC
Mutation screening by dHPLC was performed on a
Transgenomic Wave machine, designed to detect het-
eroduplexes. The screening was generally performed on
heterozygous DNAs. Otherwise, amplified DNAs were
sequenced by standard Sanger protocols in an auto-
mated sequencer.
All experiments using mice were conducted with
approval of Cornell’s Institutional Animal Care and Use
Committee, protocol # 2004-0038.
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